Is Jana Partners Right that Cooper (COO) Needs a Different Kind of Leadership?

Activist campaigns tend to surface when a stock’s performance no longer matches its story, and The Cooper Companies, Inc. (NASDAQ:COO) is a case in point. In mid-September 2026, Jana Partners, which built its stake in the contact lens maker roughly a year ago. It began pushing Cooper to replace CEO Albert White and its board chair and to explore selling all or part of its CooperVision and CooperSurgical businesses. The pressure follows a roughly 28% decline in Cooper’s stock since Jana first disclosed its position, with the activist citing what it calls inventory management and capital allocation problems and threatening a proxy fight ahead of a January nomination deadline if the company doesn’t engage.

For investors, the question is whether Cooper’s problems are a leadership issue that new management can fix quickly, or a deeper operating slowdown that a boardroom shake-up won’t solve on its own.

Look Into: Brown-Forman Corporation (BF-B) Says No to Sazerac’s $15 Billion Takeover Bid, Again

Bull Case

The Cooper Companies, Inc. (NASDAQ:COO)’s underlying business still generates meaningful cash despite the governance dispute. Third-quarter revenue reached $1.07 billion, non-GAAP earnings rose 4%, and free cash flow increased 66% to $273 million. That cash generation is supported by CooperVision’s recurring contact-lens demand. It gives the company resources to repurchase shares and address operational problems without depending on an immediate asset sale.

Jana’s campaign gives shareholders a concrete catalyst after performance setbacks. A new CEO search, a new board chair, and tighter oversight could improve inventory management and capital allocation if leadership problems, rather than weak end markets, caused Cooper’s underperformance.

Jana’s call to explore sales of CooperVision, fertility, or medical-device assets could surface value that the current conglomerate structure obscures. A well-priced transaction could simplify the company, reduce leverage, and fund repurchases. It could also force the market to value each business more clearly.

Also Read: Varex Imaging (VREX) Stock Jumps 50% on Teledyne (TDY) Buyout Deal Just as Its Turnaround Gains Traction

Bear Case

Jana’s criticism shows measurable operating weakness rather than governance concerns alone. CooperVision’s third-quarter revenue stayed flat; U.S. channel inventory reductions weighed on results. Management expects fourth-quarter organic CooperVision revenue to range from a 2% decline to no growth. New leadership cannot quickly reverse those pressures or guarantee a return to stronger growth.

Proxy fights are costly, distracting, and can take months to resolve. The threatened contest ahead of the January deadline adds real timeline pressure. It could keep The Cooper Companies, Inc. (NASDAQ:COO)’s management focused on defending its position rather than running the business day to day.

Asset sales can destroy value if Cooper negotiates from a position of pressure, accepts a weak price, or separates businesses with shared capabilities. Jana has even asked Cooper to consider selling the contact-lens franchise that supplies its strongest recurring revenue. So a poorly priced transaction could leave shareholders with a weaker collection of assets and greater dependence on the remaining segment.

Hedge Fund Sentiment

The Cooper Companies, Inc. (NASDAQ:COO) hedge fund count rose to 52 in the second quarter of 2026 from 49 in the first, with position value climbing to $2.18 billion from $1.30 billion, according to Insider Monkey’s database. Alcon, a larger eye-care rival, saw the opposite trend, with holders falling to 31 from 46 and position value dropping to $1.97 billion from $2.51 billion.

Conclusion

Cooper’s cash generation shows that Jana is targeting an underperforming business with valuable assets rather than a fundamentally broken company. The activist could improve oversight and capital allocation. But flat CooperVision revenue, channel-inventory pressure, proxy costs, and the risk of selling the core franchise create substantial execution risk. Investors should demand both measurable operating improvement and compelling transaction terms before assuming that leadership change alone will unlock value.

READ NEXT: A Failed Auction and a 15% Drop: Is Cooper Companies (COO) a Value Trap or a Bargain? and The Cooper Companies (COO) Faces Near-Term Pressure from Slowing Contact Lens Demand

Follow Insider Monkey on Google News.